Published Online: Thursday, March 1, 2007

FDA officials are advising pharmacists and patients to disregard recent news stories that they say "have created misperceptions about the effectiveness of newergeneration hormonal contraceptives."

According to the FDA, "the stories inaccurately report that the products are significantly less effective at preventing pregnancy than those approved decades ago." In truth, agency officials said, the newer-generation products are "highly effective."

The stories mistakenly suggested that the agency called a meeting to discuss the need for higher standards of efficacy for the newer products.

In reality, FDA officials said, the purpose of the meeting was "to discuss clinical trial designs that reflect the diversity of users of hormonal contraceptives, expectations for efficacy and safety, and user acceptability of the newer-generation products, including cycle control."

Latest Articles
Acute respiratory infections such as the common cold are often accompanied by cough and congestion caused by mucus hypersecretion.
Poor medication adherence is responsible for unnecessary illness, hospitalizations, disability, and premature death, particularly among patients with chronic diseases.
Police and a CVS pharmacy are on the lookout for a man who stole several boxes of diabetic test strips.
The FDA has approved Merck’s supplemental new drug application for single-dose fosaprepitant dimeglumine for injection.
Latest Issues